CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 161 enrolled
Drug / intervention
dietary intervention +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00049309
NCT00049309Phase 2Completed
CompareCT.gov

Prostate Cancer: Impact Of Fat And Flaxseed - Modified Diets

Duke University·interventional·Posted Jan 27, 2003·Updated Feb 23, 2017

In Brief

A Phase 2 clinical trial evaluating dietary intervention and flaxseed for Prostate Cancer. Completed, enrolled 161 participants across 3 sites.

Detailed Summary

RATIONALE: A diet that is low in fat and/or high in flaxseed may slow or prevent disease progression of prostate cancer. PURPOSE: Randomized phase II trial to study the effectiveness of a diet that is low in fat and/or high in flaxseed in slowing or preventing disease progression in patients who have newly diagnosed prostate cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

Phase 2CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 27, 2003
Enrollment StartJan 1, 2003
Primary CompletionMay 1, 2006
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 23.4 years ago

Interventions

dietary interventiondietary

flaxseeddietary